vs

Side-by-side financial comparison of BKV Corp (BKV) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

BKV Corp is the larger business by last-quarter revenue ($255.9M vs $197.9M, roughly 1.3× REPLIGEN CORP). BKV Corp runs the higher net margin — 27.5% vs 6.7%, a 20.8% gap on every dollar of revenue.

BKV Corp is a North American independent energy company focused on sustainable natural gas exploration, production, and distribution, with core operating assets located in the Appalachian Basin. It serves utility, industrial, and commercial customers across the region, and invests in low-carbon technologies including carbon capture to reduce operational emissions.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

BKV vs RGEN — Head-to-Head

Bigger by revenue
BKV
BKV
1.3× larger
BKV
$255.9M
$197.9M
RGEN
Higher net margin
BKV
BKV
20.8% more per $
BKV
27.5%
6.7%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKV
BKV
RGEN
RGEN
Revenue
$255.9M
$197.9M
Net Profit
$70.4M
$13.3M
Gross Margin
52.5%
Operating Margin
39.3%
9.0%
Net Margin
27.5%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.78
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKV
BKV
RGEN
RGEN
Q4 25
$255.9M
$197.9M
Q3 25
$199.8M
$188.8M
Q2 25
$207.1M
$182.4M
Q1 25
$231.0M
$169.2M
Q4 24
$174.1M
Q3 24
$133.5M
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
BKV
BKV
RGEN
RGEN
Q4 25
$70.4M
$13.3M
Q3 25
$76.8M
$14.9M
Q2 25
$104.6M
$14.9M
Q1 25
$-78.7M
$5.8M
Q4 24
$-30.3M
Q3 24
$12.9M
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
BKV
BKV
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
BKV
BKV
RGEN
RGEN
Q4 25
39.3%
9.0%
Q3 25
41.2%
8.9%
Q2 25
62.0%
7.6%
Q1 25
-40.6%
3.9%
Q4 24
-17.7%
Q3 24
-15.7%
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
BKV
BKV
RGEN
RGEN
Q4 25
27.5%
6.7%
Q3 25
38.5%
7.9%
Q2 25
50.5%
8.2%
Q1 25
-34.1%
3.4%
Q4 24
-17.4%
Q3 24
9.6%
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
BKV
BKV
RGEN
RGEN
Q4 25
$0.78
$0.24
Q3 25
$0.90
$0.26
Q2 25
$1.23
$0.26
Q1 25
$-0.93
$0.10
Q4 24
$-0.55
Q3 24
$0.18
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKV
BKV
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$199.4M
$767.6M
Total DebtLower is stronger
$486.8M
$542.2M
Stockholders' EquityBook value
$2.0B
$2.1B
Total Assets
$3.1B
$2.9B
Debt / EquityLower = less leverage
0.24×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKV
BKV
RGEN
RGEN
Q4 25
$199.4M
$767.6M
Q3 25
$83.1M
$748.7M
Q2 25
$21.4M
$708.9M
Q1 25
$15.3M
$697.2M
Q4 24
$757.4M
Q3 24
$31.3M
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
BKV
BKV
RGEN
RGEN
Q4 25
$486.8M
$542.2M
Q3 25
$486.6M
$537.9M
Q2 25
$200.0M
Q1 25
$200.0M
Q4 24
$525.6M
Q3 24
$190.0M
Q2 24
Q1 24
Stockholders' Equity
BKV
BKV
RGEN
RGEN
Q4 25
$2.0B
$2.1B
Q3 25
$1.8B
$2.1B
Q2 25
$1.6B
$2.1B
Q1 25
$1.5B
$2.0B
Q4 24
$2.0B
Q3 24
$1.6B
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
BKV
BKV
RGEN
RGEN
Q4 25
$3.1B
$2.9B
Q3 25
$2.9B
$2.9B
Q2 25
$2.3B
$2.9B
Q1 25
$2.3B
$2.9B
Q4 24
$2.8B
Q3 24
$2.3B
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
BKV
BKV
RGEN
RGEN
Q4 25
0.24×
0.26×
Q3 25
0.27×
0.26×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.27×
Q3 24
0.12×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKV
BKV
RGEN
RGEN
Operating Cash FlowLast quarter
$69.4M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
0.99×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKV
BKV
RGEN
RGEN
Q4 25
$69.4M
$25.7M
Q3 25
$74.5M
$48.1M
Q2 25
$76.2M
$28.6M
Q1 25
$22.6M
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
BKV
BKV
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$-126.9M
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
BKV
BKV
RGEN
RGEN
Q4 25
8.9%
Q3 25
-63.5%
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
BKV
BKV
RGEN
RGEN
Q4 25
4.1%
Q3 25
100.9%
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
BKV
BKV
RGEN
RGEN
Q4 25
0.99×
1.93×
Q3 25
0.97×
3.23×
Q2 25
0.73×
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BKV
BKV

Natural Gas NGL And Oil$249.3M97%
Related Party And Other$4.7M2%
Marketing$2.8M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons